Fitch pointed to slower growth and earnings swings as key risks for China and Taiwan’s life insurers, but sees stability for most of the region's life and non-life industry.
90% decline in net income comes following significant reserve release in 2023 alongside slower topline growth, but Fitch projects profitability to normalise going forward.
Ratings for nine insurers—including China Life and PICC P&C—affirmed, but negative outlook reflects pressures from market volatility and potential weakening of state support.
